FDA blocks publication of Covid-19 and shingles vaccine safety studies
Updated
Updated · KTRK-TV · May 5
FDA blocks publication of Covid-19 and shingles vaccine safety studies
14 articles · Updated · KTRK-TV · May 5
An HHS spokesperson said the studies were withdrawn because their authors made broad claims not supported by the underlying data.
The agency said it acted to protect the integrity of its scientific process and ensure work linked to the FDA meets its standards.
Earlier reports said FDA scientists had analyzed millions of patient records, found serious side effects rare, withdrew two Covid studies in October and blocked Shingrix abstracts in February.
Why were studies supporting vaccine safety blocked despite using millions of patient records and public funding, and what does this mean for scientific transparency?
How might recent funding cuts and new drug approval policies at the FDA affect future vaccine development and disease prevention efforts?
What are the potential consequences for public health if positive vaccine safety studies are withheld or blocked by regulatory agencies?